<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
    <link rel="stylesheet" href="../css/uswds.min.css">
    <link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="css/uswds.min.css">
    <link rel="stylesheet" href="css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR522.html">Part 522
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 522.1077  Gonadorelin.
                            </h3>
                            <p class="depth0"><em>(a)</em> Specifications. Each milliliter (mL) of solution contains:</p><p class="depth0"><em>(1)</em> 43 micrograms ([micro]g) of gonadorelin as gonadorelin acetate;</p><p class="depth0"><em>(2)</em> 100 [micro]g of gonadorelin as gonadorelin acetate;</p><p class="depth0"><em>(3)</em> 50 [micro]g of gonadorelin as gonadorelin diacetate tetrahydrate; or</p><p class="depth0"><em>(4)</em> 50 [micro]g of gonadorelin as gonadorelin hydrochloride.</p><p class="depth0"><em>(b)</em> Sponsors. See sponsor numbers in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(1)</em> No. 000061 for use of the 43-[micro]g/mL product described in paragraph (a)(1) as in paragraphs (d)(1)(i), (d)(1)(iv), and (d)(2) of this section.</p><p class="depth0"><em>(2)</em> No. 068504 for use of the 100-[micro]g/mL product described in paragraph (a)(2) as in paragraphs (d)(1)(ii), (d)(1)(v), and (d)(2) of this section.</p><p class="depth0"><em>(3)</em> Nos. 000859 and 050604 for use of the 50-[micro]g/mL product described in paragraph (a)(3) as in paragraphs (d)(1)(ii) and (d)(2) of this section.</p><p class="depth0"><em>(4)</em> No. 054771 for use of the 50-[micro]g/mL product described in paragraph (a)(4) as in paragraphs (d)(1)(iii), (d)(1)(vi), and (d)(2) of this section.</p><p class="depth0"><em>(c)</em> Special considerations. Concurrent luteolytic drug use is approved as follows:</p><p class="depth0"><em>(1)</em> Cloprostenol injection for use as in paragraph (d)(1)(iv) of this section as provided by No. 000061 in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(2)</em> Cloprostenol injection for use as in paragraph (d)(1)(v) of this section as provided by No. 000061 or No. 068504 in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(3)</em> Dinoprost injection for use as in paragraph (d)(1)(vi) of this section as provided by No. 054771 in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(d)</em> Conditions of use in cattle--(1) Indications for use and amounts--(i) For the treatment of ovarian follicular cysts in dairy cattle: Administer 86 [micro]g gonadorelin by intramuscular or intravenous injection.</p><p class="depth0"><em>(ii)</em> For the treatment of ovarian follicular cysts in dairy cattle: Administer 100 [micro]g gonadorelin by intramuscular or intravenous injection.</p><p class="depth0"><em>(iii)</em> For the treatment of ovarian follicular cysts in cattle: Administer 100 [micro]g gonadorelin by intramuscular injection.</p><p class="depth0"><em>(iv)</em> For use with cloprostenol injection to synchronize estrous cycles to allow for fixed-time artificial insemination (FTAI) in lactating dairy cows: Administer to each cow 86 [micro]g gonadorelin by intramuscular injection, followed 6 to 8 days later by 500 [micro]g cloprostenol by intramuscular injection, followed 30 to 72 hours later by 86 [micro]g gonadorelin by intramuscular injection.</p><p class="depth0"><em>(v)</em> For use with cloprostenol injection to synchronize estrous cycles to allow for fixed-time artificial insemination (FTAI) in lactating dairy cows and beef cows: Administer to each cow 100 [micro]g gonadorelin by intramuscular injection, followed 6 to 8 days later by 500 [micro]g cloprostenol by intramuscular injection, followed 30 to 72 hours later by 100 [micro]g gonadorelin by intramuscular injection.</p><p class="depth0"><em>(vi)</em> For use with dinoprost injection to synchronize estrous cycles to allow fixed-time artificial insemination (FTAI) in lactating dairy cows: Administer to each cow 100 to 200 [micro]g gonadorelin by intramuscular injection, followed 6 to 8 days later by 25 mg dinoprost by intramuscular injection, followed 30 to 72 hours later by 100 to 200 [micro]g gonadorelin by intramuscular injection.</p><p class="depth0"><em>(2)</em> Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[80 FR 34279, June 16, 2015]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>. Code available <a href="#">on Github.</a></h5>
      </div>
    </div>
  </footer>
  </body>
</html>
